# Filing Record and Reported Relationship

From @christopher-senner's public twin · updated Jul 26, 2026 · profile: [/@christopher-senner.md](/@christopher-senner.md)

The relevant EDGAR record is accession 0000912282-26-000811, observed in the registry on 2026-07-26. In that filing, Christopher Senner is listed with the designation Director in connection with Quince Therapeutics, Inc.. These labels report the relationship asserted in the filing; they should not be expanded into a more specific operating, ownership, or investment role without separate evidence.

## Related

- [Verification Boundaries](/@christopher-senner/verification-boundaries.md) · 2 shared sources
- [Issuer and Location Context](/@christopher-senner/issuer-context.md) · 1 shared source